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Objective: It remains incompletely understood how homocysteine impairs endothelial function. Whether
mechanisms such as calcium-activated potassium (KCa) channels are involved is uncertain and the sig-
niﬁcance of endoplasmic reticulum (ER) stress in KCa channel-dependent endothelial function in
hyperhomocysteinemia remains unexplored. We investigated the effect of homocysteine on endothelial
KCa channels in coronary vasculature with further exploration of the role of ER stress.
Methods: Vasorelaxation mediated by intermediate- and small-conductance KCa (IKCa and SKCa) channels
was studied in porcine coronary arteries in a myograph. IKCa and SKCa channel currents were recorded by
whole-cell patch-clamp in coronary endothelial cells. Protein levels of endothelial IKCa and SKCa channels
were determined for both whole-cell and surface expressions.
Results: Homocysteine impaired bradykinin-induced IKCa and SKCa-dependent EDHF-type relaxation and
attenuated the vasorelaxant response to the channel activator. IKCa and SKCa currents were suppressed by
homocysteine. Inhibition of ER stress during homocysteine exposure enhanced IKCa and SKCa currents,
associated with improved EDHF-type response and channel activator-induced relaxation. Homocysteine
did not alter whole-cell protein levels of IKCa and SKCa whereas lowered surface expressions of these
channels, which were restored by ER stress inhibition.
Conclusions: Homocysteine induces endothelial dysfunction through a mechanism involving ER stress-
mediated suppression of IKCa and SKCa channels. Inhibition of cell surface expression of these channels
by ER stress is, at least partially, responsible for the suppressive effect of homocysteine on the channel
function. This study provides new mechanistic insights into homocysteine-induced endothelial
dysfunction and advances our knowledge of the signiﬁcance of ER stress in vascular disorders.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hyperhomocysteinemia has been long recognized as an inde-
pendent risk factor for atherosclerotic diseases. The strong cor-
relation between plasma concentration of homocysteine (Hcy)
and mortality of coronary artery disease further established the
prognostic value of Hcy levels in cardiovascular patients [1].
Endothelial dysfunction is of great importance in the pathogenesisepartment of Medicine and
ong Kong.
Ireland Ltd. This is an open accessof the vascular complications of hyperhomocysteinemia [2,3]. So
far the molecular basis underlying Hcy-induced endothelial
dysfunction has not been fully understood, although several
mechanisms including downregulation of endothelial nitric oxide
synthase (eNOS) expression and overproduction of reactive oxy-
gen species [4,5] have been proposed as being responsible for
decreased bioavailability of nitric oxide (NO). We recently
demonstrated that iNOS-arginase activation also contributes to
the loss of eNOS-NO function in coronary arteries exposed to Hcy
[6].
Ca2þ-activated Kþ (KCa) channels are important to vascular
endothelial function. Opening of intermediate- and small-
conductance KCa (IKCa and SKCa) channels on the plasmaarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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classical endothelium-derived hyperpolarizing factor (EDHF)
pathway [7]. In addition, the capacity of IKCa and SKCa channels in
endothelial [Ca2þ]i modulation further highlights the signiﬁcance
of these channels in the regulation of vascular tone. For example,
the channel opening-induced hyperpolarization has been sug-
gested to enhance driving force for Ca2þ entry in endothelial cells,
leading to the Ca2þ-dependent eNOS activation and subsequent NO
production [8].
There are only a few studies so far examining the effect of Hcy on
EDHF-mediated vasodilation. Renal blood ﬂow in response to
acetylcholine under combined blockade of NO synthase and
cyclooxygenase was suppressed signiﬁcantly in hyper-
homocysteinemic rats (plasma Hcy 33e74 mmol/L) compared with
non-diseased animals [9], suggesting the unfavorable effect of Hcy
on EDHF. Similar inhibition of EDHF-mediated relaxation was
observed in small mesenteric arteries in transgenic cystathionine
beta synthase-deﬁcient mice of severe hyperhomocysteinemia
(plasma Hcy ~170 mmol/L) [10]. The ﬁndings of the decreased efﬁ-
ciency of IKCa and SKCa channel blockers in inhibiting EDHF-
mediated relaxation in hyperhomocysteinemic mice for the ﬁrst
time suggested the role of KCa channel inactivation in Hcy-induced
loss of EDHF-response [10]. Nevertheless, direct evidence regarding
the inactivation of endothelial IKCa and SKCa channels by Hcy is still
missing. Furthermore, the mechanisms by which Hcy affects IKCa
and SKCa channels and the channel related endothelial function
remain poorly studied.
A growing body of evidence implicates the involvement of
endoplasmic reticulum (ER) stress in the pathogenesis of cardio-
vascular diseases [11]. Recent studies have begun to uncover the
signiﬁcance of ER stress in vascular endothelial dysfunction in hy-
pertension [12] and diabetes [13] with the ﬁndings of ER stress-
dependent inhibition of eNOS-NO pathway. It remains unex-
plored whether other mechanisms, e.g., EDHF (via IKCa and SKCa)
are involved in ER stress-induced endothelial dysfunction.
In this study, we systematically investigated the effect of Hcy,
which is known as an ER stressor [14e16], on endothelial IKCa and
SKCa channels in vitro in coronary vasculature with further explo-
ration of the role of ER stress. Experiments performed at different
levels including channel current recording, analyses of whole-cell
and surface expression of the channels, as well as the channel-
mediated vasorelaxation aim to provide new mechanistic insight
into endothelial dysfunction caused by Hcy and advance our
knowledge of the signiﬁcance of ER stress in the endothelial control
of vascular tone in hyperhomocysteinemia.2. Materials and methods
Fresh porcine hearts of young adult pigs (~35 kg) were collected
from a local slaughterhouse. Once excised, the hearts were placed
in a container ﬁlled with cold (4 C), pre-oxygenated (95%O2/5%
CO2) Krebs solution and immediately transferred to the laboratory
for dissection of small coronary arteries as in our previous studies
[6,17,18]. All experiments were in accordance with institutional
guidelines. The study was approved by the Animal Experimenta-
tion Ethics Committee, and Safety Ofﬁce of the Chinese University
of Hong Kong (Ref. No. 14/010/GRF).2.1. Isolation and primary culture of porcine coronary endothelial
cells (PCECs)
PCECs were isolated by enzymatic digestion from porcine cor-
onary arteries and cultured as previously described [17,18]. Further
details were given in Supplementary Methods.2.2. Determination of cell viability
Cell viability was determined by trypan blue dye exclusion assay
[17] (see Supplementary Methods for details).
2.3. Patch-clamp recording of IKCa and SKCa channel currents in
PCECs
Whole-cell Kþ currents of PCECs were recorded by patch-clamp
(EPC10, HEKA, Lambrecht, Germany) at room temperature
(20e24 C) with further differentiation of the IKCa and SKCa com-
ponents [18] (see Supplementary Methods for details).
2.4. Isometric force study
Porcine small coronary arteries with the diameter of
300e500 mm were dissected from the branches of left anterior
descending artery (LAD) and cut into cylindrical rings with 2-mm in
length. The rings were mounted, normalized, and equilibrated in a
four-channel Mulvany myograph (Model 610M, J.P.Trading, Aarhus,
Denmark) as previously described [6,17,18]. Relaxant responses
induced by bradykinin and by the IKCa and SKCa activator NS309
[19] were determined following U46619 pre-contraction.
2.5. Western blot analysis
Whole cell lysates of PCECs were used for protein expression
analysis of KCa3.1, KCa2.3, and ER stress molecules 78-kDa glucose-
regulated protein (GRP78), protein kinase RNA-like endoplasmic
reticulum kinase (PERK), and phosphorylated (Thr980) PERK. De-
tails were described in Supplementary methods.
2.6. Biotinylation assay of surface proteins
Cell surface protein isolation of PCECs was performed using the
Pierce cell surface protein isolation kit (Thermo Scientiﬁc) as in our
previous study [17]. Surface expressions of KCa3.1 and KCa2.3 were
detected by western-blotting (see Supplementary methods for
details).
2.7. Experimental protocols
2.7.1. Protocol 1. Effect of Hcy on IKCa and SKCa channel-mediated
relaxation in coronary arteries e role of ER stress
2.7.1.1. Protocol 1.1. Effect of ER stress inducer on IKCa and SKCa
channel activator-induced relaxation. Small coronary arteries taken
from the same branch of LAD were allocated to the following
treatment groups: control, tunicamycin (ER stress inducer, 5 mg/
ml), 4-phenylbutyric acid (4-PBA, ER stress inhibitor, 2 mmol/L),
tauroursodeoxycholate (TUDCA, ER stress inhibitor, 200 mmol/L),
tunicaymycinþ4-PBA, and tunicamycin þ TUDCA. After 4-h expo-
sure, vasorelaxant responses to the IKCa and SKCa activator NS309
(9~5.5 Log M) were determined in U46619-preconstriction.
2.7.1.2. Protocol 1.2. Effect of ER stress inducer on IKCa and SKCa
channel-dependent EDHF-mediated relaxation. Small coronary
arterial rings were grouped and treated as above. The vessels were
then precontracted by U46619 and bradykinin (10~6.5 LogM)-
induced, IKCa and SKCa channel-dependent EDHF-mediated relax-
ation were studied in the presence of cyclooxygenase inhibitor
indomethacin (Indo, 7 mmol/L), NOS inhibitor NG-nitro-L-arginine
(L-NNA, 300 mmol/L), and NO scavenger oxyhemoglobin (HbO,
20 mmol/L) [20,21].
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mediated relaxation in coronary arteries exposed to Hcy. Small cor-
onary arterial rings taken from the same branch of LAD were
allocated and treated as: control, 4-PBA, TUDCA, Hcy (100 mmol/L),
Hcyþ4-PBA, and Hcy þ TUDCA. Dose-dependent relaxations
induced by NS309 and by bradykinin in the presence of Indo, L-
NNA, and HbO were studied in U46619-preconstriction after 24-h
treatment.2.7.2. Protocol 2. Effects of Hcy on whole-cell and surface
expression of IKCa and SKCa channels in coronary endothelial cells e
role of ER stress
2.7.2.1. Protocol 2.1. Whole-cell protein expression of IKCa and SKCa
channels e role of ER stress. PCECs were divided to six groups and
treated for 24 h as: control, 4-PBA, TUDCA, Hcy, Hcy plus either 4-
PBA or TUDCA. Cells were collected and whole cell lysate were used
for western-blot analyses of KCa3.1, KCa2.3, and the ER stress
markers including GRP78 and PERK.2.7.2.2. Protocol 2.2. Cell surface expression of IKCa and SKCa channels
e role of ER stress. PCECs were allocated to the following treatment
groups: control, Hcy, Hcy þ TUDCA, and TUDCA. Cells were
collected after 24-h with the plasma membrane extracted for
determination of the cell surface expression of KCa3.1 and KCa2.3.Fig. 1. Vasorelaxant responses of porcine small coronary arteries to the IKCa and SKCa channe
and 24-h exposure to homocysteine (Hcy) (c). The IKCa and SKCa channel-dependent, EDHF
nitro-L-arginine, and oxyhemoglobin is also inhibited by tunicamycin (b) and Hcy exposu
(TUDCA) and 4-phenylbutyric acid (4-PBA) preserves the relaxant response to NS309 and pr
For each group, data represent 8 independent experiments (8 vessels taken from 8 different h2.7.3. Protocol 3. Effect of Hcy on IKCa and SKCa channel currents e
role of ER stress
PCECs were allocated to the following treatment groups: con-
trol, Hcy, Hcy þ TUDCA, and TUDCA. Basal Kþ currents and Kþ
currents activated by NS309 or induced by bradykinin without or
with the presence of Indo, L-NNA, and HbO were recorded with
further differentiation of IKCa and SKCa components.
2.8. Data analysis
Relaxation was expressed as the percentage decrease of pre-
contraction induced by U46619. All data were presented as
mean ± s.e.m. Statistical analyses were performed by one-way
ANOVA followed by Scheffe tests (SPSS, version 20). Differences
were considered as signiﬁcant at p < 0.05.
3. Results
3.1. ER stress impairs IKCa and SKCa channel-mediated relaxation in
coronary arteries
The IKCa and SKCa channel activator NS309 induced dose-
dependent relaxation in porcine small coronary arteries. Incuba-
tion of the arteries with the ER stressor tunicamycin signiﬁcantly
inhibited NS309-induced relaxation (Rmax: 43.7 ± 5.8% vs.l activator NS309 are attenuated after 4-h exposure to ER stressor tunicamycin (TM) (a)
-mediated relaxation in response to bradykinin in the presence of indomethacin, NG-
re (d). Co-incubation of the arteries with ER stress inhibitors, tauroursodeoxycholate
otects the EDHF-type relaxation in both TM- (a & b) and Hcy- (c & d) exposed arteries.
earts). *p < 0.05, **p < 0.01, ***p < 0.001 vs. control; #p < 0.05, ##p < 0.01 vs. TM or Hcy.
Fig. 2. Twenty-four hour exposure to homocysteine (Hcy) induces ER stress in porcine
coronary endothelial cells, evidenced by increased protein expression of GRP78/Bip (a,
n ¼ 6) and enhanced phosphorylation of PERK (b, n ¼ 4). Both tauroursodeoxycholate
(TUDCA) and 4-phenylbutyric acid (4-PBA) effectively inhibit ER stress in Hcy-exposed
cells. N indicates the number of independent experiments, each obtained from cell
isolates of different heart. *p < 0.05, **p < 0.01.
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stress inhibitors, 4-PBA (78.7 ± 6.9%, p < 0.01 vs. tunicamycin) and
TUDCA (67.8 ± 4.3%, p < 0.05 vs. tunicamycin) (Fig. 1a). In the
presence of inhibitors of cyclooxygenase and NOS as well as NO
scavenger, the IKCa and SKCa channel-dependent EDHF-mediated
relaxation induced by bradykinin (86.4 ± 4.3%) was also observed
being suppressed by tunicamycin (44.2 ± 7.1%, p < 0.001) and
restored by co-incubationwith either 4-PBA (71.5 ± 4.5%) or TUDCA
(66.3 ± 5.0%) (p < 0.05 vs. tunicamycin) (Fig. 1b).
3.2. ER stress mediates Hcy-induced functional loss of endothelial
IKCa and SKCa channels in coronary arteries
Exposure to Hcy induced ER stress in coronary endothelium,
evidenced by increased expression of GRP78 and enhanced
phosphorylation of PERK, which are classical ER stress markers
[22,23]. Both 4-PBA and TUDCA effectively inhibited ER stress in
Hcy-exposed PCECs (Fig. 2). Exposure to Hcy for 24 h did not alter
the resting force of coronary arteries and there were no signiﬁcant
differences among groups with regard to U46619-induced precon-
traction (data not shown), whereas vasorelaxant response to the
IKCa and SKCa activator NS309 was signiﬁcantly attenuated
(66.1 ± 6.2% vs. 90.4 ± 1.9%, p < 0.01) (Fig. 1c). Furthermore,
bradykinin-induced, IKCa and SKCa channel-dependent EDHF
response was also inhibited in Hcy-exposed arteries (49.2 ± 3.8%
vs. 77.1 ± 2.5%, p < 0.001) (Fig. 1d). Additional experiments using
cysteine, a byproduct naturally produced by Hcy in vivo, showed
no alterations in both NS309-induced and EDHF-mediated relax-
ation after 24-h exposure to equimolar concentration of cysteine,
suggesting the inhibitory effect on IKCa and SKCa channel-
mediated vasorelaxation was speciﬁc for Hcy (Supplementary
results Fig. 1). Co-incubation with ER stress inhibitors 4-PBA or
TUDCA during Hcy exposure preserved the function of IKCa and
SKCa channels in vasorelaxation. The maximal relaxant response to
NS309 was 87.1 ± 2.2% in Hcy-exposed arteries with 4-PBA
treatment, and 89.8 ± 3.8% with TUDCA treatment. The inhibi-
tory effect of Hcy on IKCa and SKCa channel-dependent EDHF-
mediated relaxation was prevented by 4-PBA (70.3 ± 4.5%) and
TUDCA (70.0 ± 3.2%). In arteries without Hcy exposure, the ER
stress inhibitor itself did not affect IKCa and SKCa channel-
mediated vasorelaxation (Fig. 1c and d).
3.3. Inhibition of ER stress enhances IKCa and SKCa channel currents
in coronary endothelial cells exposed to Hcy
Whole-cell Kþ currents in PCECs were signiﬁcantly inhibited
by Hcy. Both basal current (20.79 ± 1.24 vs. 32.78 ± 1.72 pA/pF in
control) and current in response to bradykinin (29.18 ± 3.53 vs.
64.13 ± 1.86 pA/pF in control) (Fig. 3a) or to NS309 (31.91 ± 2.03
vs. 54.21 ± 4.66 pA/pF in control) (Fig. 3c) were attenuated.
Further differentiation of IKCa and SKCa components using speciﬁc
IKCa and SKCa blockers, TRAM-34 and apamin [24,25] showed that
IKCa current induced by bradykinin decreased from
19.52 ± 2.80 pA/pF to 4.68 ± 0.79 pA/pF (p < 0.01) and from
14.93 ± 1.87 pA/pF to 6.31 ± 0.83 pA/pF (p < 0.01) in NS309-
stimulated cells after Hcy exposure. Meanwhile, bradykinin-
induced SKCa current decreased from 8.17 ± 1.42 pA/pF to
2.94 ± 0.69 pA/pF (p < 0.05) and SKCa current in response to
NS309 declined from 11.38 ± 2.29 pA/pF to 5.28 ± 0.94 pA/pF
(p < 0.05) in Hcy-exposed cells (Fig. 3b and d) (also see
Supplementary results Fig. 2b and d). Inhibition of ER stress by
TUDCA during Hcy exposure enhanced both IKCa and SKCa cur-
rents. IKCa and SKCa currents induced by bradykinin were
increased to 11.92 ± 1.02 pA/pF and 6.05 ± 0.46 pA/pF respec-
tively, and the response to NS309 was enhanced to 9.59 ± 1.61 pA/pF for IKCa and 8.33 ± 0.62 pA/pF for SKCa (Fig. 3b and d) (also see
Supplementary results Fig. 2b and d).
3.4. ER stress induced by Hcy inhibits cell surface expression of IKCa
and SKCa channels in coronary endothelial cells
After 24-h exposure to Hcy, the overall protein expression of IKCa
and SKCa channels in PCECs remained unchanged (Fig. 4) whereas
the surface protein levels of IKCa and SKCa signiﬁcantly decreased
(Fig. 5). Inhibition of ER stress reversed the IKCa and SKCa down-
regulation at cell surface.
4. Discussion
The present study for the ﬁrst time demonstrated that in
Fig. 3. Homocysteine (Hcy) exposure suppresses IKCa (TRAM-34-sensitive) and SKCa (apamin-sensitive) channel currents in porcine coronary endothelial cells. Pre-treatment of the
cells with the ER stress inhibitor tauroursodeoxycholate (TUDCA) shows protective effect against Hcy on IKCa and SKCa currents. Original traces and IeV curves of whole-cell Kþ
currents in response to bradykinin (BK) (a) and NS309 (c) in cells from different treatment groups before and after application of TRAM-34 and apamin. *p < 0.05, **p < 0.01, BK or
NS309 vs. basal; #p < 0.05, ##p < 0.01 BK þ TRAM-34 vs. BK, or NS309 þ TRAM-34 vs. NS309; ^p < 0.05, ^^ p < 0.01, BK þ TRAM-34 þ Apamin vs. BK þ TRAM-34, or NS309 þ TRAM-
34 þ Apamin vs. NS309 þ TRAM-34. Summarized data of BK- (b) and NS309-induced (d) IKCa and SKCa currents from 5 independent experiments, each obtained from cell isolates of
different heart. *p < 0.05, **p < 0.01.
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IKCa and SKCa channels in vasorelaxation; 2) Hcy induces endo-
thelial dysfunction through a mechanism involving ER stress-
mediated inhibition of IKCa and SKCa channels; and 3) Suppres-
sion of surface expression of IKCa and SKCa proteins by ER stress in
endothelial cells is at least partially responsible for the channel
inhibition caused by Hcy.
Endothelial IKCa and SKCa channels play an important role in
vascular tone regulation. In addition to numerous evidence from
animal studies, a growing body of research in recent years has
demonstrated the pathophysiological importance of these channelsin human circulation. Upregulation of KCa2.3 and KCa3.1 expressions
by laminar shear stress helps maintain endothelial cell homeostatic
functions such as adaptation to hemodynamic changes in human
coronary artery [26]. Patients undergoing cardiopulmonary bypass
surgery exhibit disturbed dilator responses in skeletal muscle ar-
terioles and coronary microvasculature, which is associated with
diminished endothelial KCa2.3 and KCa3.1 functions [27,28]. These
human studies further highlight the signiﬁcance of IKCa and SKCa
channels in vascular function.
Hcy is a thiol-containing amino acid that is biosynthesized
in vivo from methionine [29]. Ever since the importance of
Fig. 4. Whole cell protein expressions of IKCa (a) and SKCa (b) channels are not affected
by 24-h exposure to homocysteine. n ¼ 6 in each group. N indicates the number of
independent experiments, each obtained from cell isolates of different heart.
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ﬁrst recognized in the 1960's, subsequent studies in multiple ani-
mal models have proven that Hcy is directly atherogenic, causing
vascular endothelial dysfunction which is of great signiﬁcance in
progressive arteriosclerotic plaque development [2,30]. Mecha-
nisms underlying Hcy-induced endothelial dysfunction include
downregulation of eNOS expression [4,31], elevation of O2 pro-
duction [5], and inhibition of arginine transport [32], resulting in
the reduction of NO bioavailability. Recent evidence suggests the
role of iNOS-dependent arginase activation in the loss of eNOS-NO
function after Hcy exposure [6]. Nevertheless, despite advances in
understanding the molecular link between Hcy and endothelial
dysfunction, much still remains unknown including whether Hcy
affects EDHF-response by imposing effects on endothelial KCa
channels and whether ER stress is involved.
ER stress occurs in coronary endothelial cells exposed to
100 mmol/L Hcy. Such concentration of Hcy is relevant to clinical
plasma levels of moderate hyperhomocysteinemia (31e100 mmol/
L) [33]. We observed an increased expression of GRP78 (also
referred to as immunoglobulin heavy chain binding protein, BiP)
and an enhanced phosphorylation of PERK after Hcy exposure. As a
best characterized ER chaperone, GRP78/BiP initiates the ER stress
response by controlling the activation of the transmembrane ER
stress sensors, e.g., PERK, through a binding-release mechanism.
Therefore, upregulation of GRP78/BiP expression and PERK phos-
phorylation have beenwidely used as markers for ER stress [22,23].
In the present study, with elimination of the role of PGI2 and NO
by using cyclooxygenase and NOS inhibitors and NO scavenger
[20,21], we observed signiﬁcant attenuation of EDHF-type relaxa-
tion in coronary arteries after Hcy exposure. Inhibition of ER stress
preserved the EDHF-response, indicating the role of ER stress in
Hcy-induced impairment of EDHF component. Relaxation studies in
arteries pretreated with the ER stress inducer tunicamycin provided
parallel evidence that EDHF-type response is prone to ER stress.
Further patch-clamp recording showed that Hcy reduces IKCa
and SKCa channel currents in coronary endothelial cells. Inhibition
of ER stress during Hcy exposure enhances IKCa and SKCa currents,
associated with an improved relaxant response of coronary arteries
to the IKCa and SKCa channel opener. The ER stress-mediated inhi-
bition of endothelial IKCa and SKCa channels provides a mechanistic
explanation for Hcy-induced impairment of EDHF-type
vasorelaxation.
To understand whether the channel modulation is due to
altered expression of IKCa and SKCa channels, western-blotting was
performed to determine protein levels of KCa3.1 and KCa2.3. Previ-
ous investigation demonstrated that among the three subtypes of
SKCa [KCa2.1 (SK1), KCa2.2 (SK2) and KCa2.3 (SK3)], no mRNA
encoding SK1 is detected in porcine coronary endothelium and the
apamin-sensitive component of the EDHF-response is mediated by
SK3 while not by SK2 [34]. Indeed, transgenic studies have revealed
the fundamental role of endothelial KCa2.3 and KCa3.1 (IKCa) chan-
nels in vascular tone and blood pressure regulation [35,36]. Our
results showed that 24-h Hcy exposure did not alter protein ex-
pressions of KCa3.1 and KCa2.3 at whole-cell level but signiﬁcantly
downregulated cell surface expression of these channels. Inhibition
of ER stress restored the downregulation, suggesting that ER stress
is a key mediator of the inhibitory effect of Hcy on the cell surface
expression of IKCa and SKCa channels.
Although inhibition of ER stress restored Hcy-induced down-
regulation of surface expression of IKCa and SKCa channels, it only
partially restored the whole-cell IKCa and SKCa channel currents.
Since whole-cell current is determined not only by the number of
channels at the surface but also single channel activity, our ﬁndings
of the partial restoration of the channel currents may therefore
suggest that 1) in addition to inhibiting cell surface expression ofIKCa and SKCa channels, Hcy is likely to inhibit channel activity of
IKCa and SKCa; 2) ER stress is not the only mechanism underlying
Hcy-induced IKCa and SKCa channel inhibition. So far, knowledge
regarding the regulation of endothelial KCa channel activity remains
quite limited. It was reported that oxidative stress may inhibit IKCa
channel activity by oxidizing sulfhydryl groups involved in the
gating of the channel [37,38]. The ﬁndings of SKCa protein binding
with protein kinase CK2 and protein phosphatase 2A, as well as the
putative PKA/PKG consensus phosphorylation site (Ser334) in IKCa
are evidence supporting post-translational regulation of KCa chan-
nel activity [38,39]. Whether these mechanisms are involved in
Hcy-induced inhibition of IKCa and SKCa channel activity, however,
warrant further studies.
4.1. Limitations of the study
Whereas 100 mmol/L Hcy is comparable to pathophysiological
levels observed in homocystinuric subjects [40], less marked
Fig. 5. Twenty-four hour exposure to homocysteine decreases the surface expression of IKCa (a) and SKCa channels (b) in porcine coronary endothelial cells, which is restored by ER
stress inhibition. N ¼ 4 in each group. N indicates the number of independent experiments, each obtained from cell isolates of different heart. *p < 0.05, **p < 0.01.
X.-C. Wang et al. / Atherosclerosis 242 (2015) 191e198 197elevations in plasma homocysteine (15e30 mmol/L) are much more
common in hyperhomocysteinemic patients. In this study, Hcy
concentration higher than the typical plasma levels was used out of
consideration that in vitro studies in isolated cells and vessels have
restraints in time of exposure. Trypan blue assay shows no changes
in overall viability of PCECs after 24-h treatment with 100 mmol/L
Hcy (94.2 ± 0.4% vs. 93.5 ± 0.6% in control, comparisonmade from 6
independent experiments), which is consistent with previous
in vitro studies using high Hcy concentration. For example, cell
viability remained unchanged in bovine aortic endothelial cells
subjected to 24-h Hcy exposure (0.5 and 2.5 mmol/L) [32] and in
human umbilical vein endothelial cells (HUVECs) exposed to
0.1e5 mmol/L Hcy for up to 24 h [14]. Signiﬁcant cell death was not
even observed in HUVECs incubated with 1 mmol/L Hcy after a few
days [41]. The ﬁndings of only mild increases in intracellular con-
centrations of Hcy (2e5-fold) in HUVECs subjected to millimolar
concentrations of exogenous Hcy provided an explanation on the
relative resistance of endothelial cells to high doses of Hcy in vitro
[14]. While using higher concentrations of Hcy for limited exposure
time (i.e, 24 h) provides a reasonable in vitro model to study the
mechanism of the cellular effect of Hcy and such discrepancies are
not unusual in in vitro studies, investigations with typical plasma
concentrations for prolonged exposure period (i.e., weeks or
months) and even in vivo studiesmay yield results more relevant to
clinical practice. This should be taken into account in future studies.
In this study, we demonstrated inhibition of cell surface
expression of KCa3.1 and KCa2.3 by ER stress is a mechanism un-
derlying the suppressive effect of Hcy on endothelial KCa channels.
Whether the decrease in cell surface expression of these channels is
due to forward trafﬁcking inhibition that may start with improper
folding/assembly of the channel proteins in the ER, or/and results
from enhanced endocytosis of these channels represents a topic
worthy of deeper exploration. In addition, althoughwewere able to
characterize the central role of ER stress in Hcy-induced endothelial
KCa channel dysfunction in coronary arteries, the present study
made no further attempt to explore the signiﬁcance of the indi-
vidual ER stress sensoring, i.e., PERK, inositol requiring enzyme 1
(IRE1), and activating transcription factor (ATF6) [42] in the mod-
ulation of KCa channels. Further explorations on intracellular
signaling via ER stress sensors are warranted to provide a more
profound understanding of the mechanisms behind ER stress-
mediated regulations of surface expression of IKCa and SKCa
channels.
In conclusion, the present study demonstrated that Hcy induces
endothelial dysfunction through a mechanism involving ER stress-
mediated suppression of IKCa and SKCa channels. Inhibition of cellsurface expression of these channels by ER stress is, at least
partially, responsible for the inhibitory effect of Hcy on the channel
function. This study provides new mechanistic insights into Hcy-
induced endothelial dysfunction and advances our knowledge of
the signiﬁcance of ER stress in vascular pathology, which may help
identify new potential target sites for vascular protection in
hyperhomocysteinemia.
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